H2 Green Steel vs Andson Biotech

Side-by-side comparison of AI visibility scores, market position, and capabilities

Andson Biotech leads in AI visibility (41 vs 18)
H2 Green Steel logo

H2 Green Steel

EmergingClimate & Energy

General

Boden Sweden green hydrogen steel plant (rebranded from H2 Green Steel to Stegra 2024); €6.5B funded with 800MW electrolyzer and Volvo/Mercedes/Porsche pre-sales at 20-30% premium targeting 5M tonnes by 2030.

AI VisibilityBeta
Overall Score
D18
Category Rank
#368 of 1158
AI Consensus
51%
Trend
up
Per Platform
ChatGPT
29
Perplexity
25
Gemini
21

About

Stegra (formerly H2 Green Steel, rebranded 2024) is a Boden, Sweden-based green steel manufacturer — backed with approximately €6.5 billion in total funding from investors including Schaeffler (€100M total), Vargas Holding, and 20+ strategic and financial investors spanning the founder of Spotify to industrial corporations — building Europe's first large-scale green hydrogen steel plant in Boden, 45 miles south of the Arctic Circle, with operations expected by end of 2025 and commercial production ramping in 2026 toward 5 million tonnes annually by 2030. Founded in 2020 by Vargas Holding (the same investment group behind Northvolt), Stegra is led by CEO Henrik Henriksson (former CEO of Scania). The Boden facility features Europe's largest green hydrogen electrolyzer (800 MW), a MIDREX H2 DRI (direct reduced iron) plant, and a downstream steel mill supplied by SMS Group — replacing the coal-based blast furnace process with green hydrogen electrolysis, producing steel with up to 95% less CO2 than conventional production. Stegra has pre-sold over 50% of planned production capacity at 20-30% price premiums to customers including Volvo Group, Mercedes-Benz, Porsche, and IKEA's parent Ingka Group.

Full profile
Andson Biotech logo

Andson Biotech

EmergingHealthcare

General

Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.

AI VisibilityBeta
Overall Score
C41
Category Rank
#220 of 1158
AI Consensus
62%
Trend
up
Per Platform
ChatGPT
49
Perplexity
36
Gemini
40

About

Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.

Full profile

AI Visibility Head-to-Head

18
Overall Score
41
#368
Category Rank
#220
51
AI Consensus
62
up
Trend
up
29
ChatGPT
49
25
Perplexity
36
21
Gemini
40
14
Claude
41
9
Grok
51

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.